Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts. (Q40711564)
Jump to navigation
Jump to search
scientific article published on August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts. |
scientific article published on August 2002 |
Statements
Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts (English)
Rosalba Salcedo
Barry Gertz
Joost J Oppenheim
1 August 2002